|Systematic (IUPAC) name|
|Poly[[1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide]ethylene- co-[(piperazin-1,4-diyl 1-oxide)ethylene]]|
|Bioavailability||up to 89%|
|Half-life||25.4 hours (intravenous routes)|
|Mol. mass||60000–100000 g/mol|
Azoximer bromide is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.
- State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|